Incyte Corporation Wins FDA Approval for Jakafi XR
WILMINGTON, Del., May 1, 2026 Incyte Corporation has secured U.S. Food and Drug Administration (FDA) approval for Jakafi XR™...
Oncology
Advertisement
Arvinas Inc Gains FDA Approval for VEPPANU PROTAC Drug
NEW HAVEN, Conn., May 1, 2026 Arvinas, Inc., in collaboration with Pfizer Inc., announced that the U.S. Food and...
Pfizer ELREXFIO Phase 3 Trial Improves Survival Outcomes
New York, United States | April 29, 2026 Pfizer Inc. has reported positive Phase 3 clinical trial results for...
Diakonos Oncology Reports Phase 1 DOC1021 Survival Data
Houston, USA | May 1, 2026 Diakonos Oncology has reported positive Phase 1 clinical data for its investigational DOC1021...
AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer
WASHINGTON, D.C., April 30, 2026 AstraZeneca announced that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC)...
Advertisements
BeOne Medicines Gains FDA Priority Review for TEVIMBRA
SAN CARLOS, CALIFORNIA, April 29, 2026 BeOne Medicines has announced that the U.S. Food and Drug Administration (FDA) has...
Immunome Files FDA NDA for Varegacestat in Tumors
BOTHELL, WASHINGTON, April 29, 2026 Immunome has announced the submission of a New Drug Application (NDA) to the U.S....
EnGeneIC Doses First Patient in GBM EDV Therapy Trial
SYDNEY, AUSTRALIA, May 01, 2026 EnGeneIC has announced a critical clinical milestone with the first patient dosed in its...
IDEAYA Advances NDA for Darovasertib Under FDA RTOR
SOUTH SAN FRANCISCO, CALIFORNIA, April 30, 2026 IDEAYA Biosciences has announced that the U.S. Food and Drug Administration (FDA)...
Laguna Gains FDA IND Clearance for LGNA-100 Therapy
SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
